Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation Inhibition With LNG POP During Three Cycles With Intentional Intake Errors
2025-521236-12-00Phase 2Completed
- Sponsor
- SocraTec R&D
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of avatrombopag in contraception, sponsored by SocraTec R&D. Primary endpoint: Ovulation under treatment. Started Jun 2025; status: completed.
02
Drugs
avatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on 2025-521236-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521236-12-00.